BioSpace News Archive

The Muscular Dystrophy Association (MDA) today announced that Don Cheadle, Common, Cindy Crawford, Whitney Cummings, Stephen Curry, Zachary Levi, and Kelly Rowland will join the previously announced star-studded lineup for The MDA Kevin Hart Kids Telethon.

Intrommune Therapeutics has announced an expanded partnership with Circuit Clinical, a leading Integrated Research Organization (IRO). Based on this deal, Circuit Clinical will oversee the early clinical development of Intrommune’s lead drug, INT301, including a Phase 1b study planned for Q4 2020 and Q1 2021. “We are excited about the opportunity to partner with Circuit Clinical to support the development of peanut INT301,” said Michael Nelson, CEO

GigaGen Inc. , a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, announced today publication of a peer-reviewed article titled, “Affinity maturation of antibodies by combinatorial codon mutagenesis versus error-prone PCR,” in the peer-reviewed journal mAbs. The publication is available online here. GigaGen’s newly published data detai

InstaShield, maker of the original ball-cap face shield, has been named one of the winners of the 19th annual Chicago Innovation Awards.

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapy, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced it will release its third quarter 2020 financial results before the market opens on Thursday, October 29, 2020. Agenus executives will host a conference call and webcast at 8:30 a.m. ET the same day to discuss the result

Nascent Biotech, Inc. is pleased to announce that the Company has received initial In-Vitro study results from its collaboration with Syracuse University showing that Pritumumab successfully blocked viral entry into cells.

AstraZeneca’s TAGRISSO ® (osimertinib) has received acceptance for its supplemental New Drug Application (sNDA) and has also been granted Priority Review in the US for the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated

Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2020, before the open of the financial markets on Thursday, October 29, 2020. Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financ

SDNA-1000 EUA authorization offers a direct path to the most robust and safest sample collection approach for detecting COVID-19 infections and pioneers a new era of at-home self-collection for the diagnosis of viral infections

Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory M. Glenn, M.D, President of Research & Development, will present on NVX-CoV2373, the Company’s COVID-19 vaccine, at the 2020 World Vaccine Congress Europe. The Congress takes place virtually October 19 - 21, 2020. Presentation Title : Recombinant nanoparticle COVID-19 vac